The major players in the Acute Kidney Injury Therapeutics market include AngionBiomedica Corp., AM-Pharma, Quark Pharmaceuticals, Inc., Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA., B. Braun Melsungen AG, Asahi Kasei Medical Co., Ltd., and LG Chem., and Others.
The increasing cases for AKI worldwide due to the fast paced lifestyle resulting in the changed eating habits is expected to drive the market. The governments are taking initiatives for disease- related R&D for new treatment technique and drugs which is likely to encourage the market growth. Additionally, the increase in disposable income is leading the population towards health consciousness which substantially is allowing them to spend more on health and lifestyle. However, lack of awareness about this disease in under-developed countries and higher cost of treatment is likely to hamper the market growth.
The entire Acute Kidney Injury Therapeutics market has been sub-categorized into injury type, therapy and Distribution channel. current and future demand for Acute Kidney Injury Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
By Injury Type
- Pre-renal
- Intrinsic renal
- Post-renal
By Therapy
- Intermittent hemodialysis
- Continuous renal replacement therapy
- Sustained low-efficiency dialysis
By Distribution Channel
- Hospital Pharmacies
- Online Pharmacies
- Others
Source: https://www.valuemarketresearch.com/report/acute-kidney-injury-therapeutics-market
Naira Shekhawat has been into Content Writing just after completing her Graduation in English Literature. Her love for words has won her many accolades in her respective jobs ever since. Naira covers business sections for VMR News. She is a traveller by heart and loves writing on food blogs as a freelancer.